Skip to main content
Premium Trial:

Request an Annual Quote

S2 Genomics Inks Canadian Distribution Deal With D-Mark Bioscences

NEW YORK – S2 Genomics has entered into a distribution agreement with D-Mark Biosciences in Canada for the promotion, sale, and support of S2's Singulator 100 system and associated products for single-cell genomics and cell biology applications.

The Singulator 100 system isolates single cells or nuclei from solid tissue samples, enabling the production of high-quality, single-cell data from difficult tissue types. The system features single-use disposable cartridges and proprietary reagents to automate tissue dissociation, and allows users to create their own dissociation protocols, use their own reagents, and dissociate tissue at low temperature to minimize changes to cell transcriptomes.

"Canada is experiencing significant growth in single-cell genomic and cell biology markets, creating a need for improved single-cell preparation solutions," S2 Genomics CEO Stevan Jovanovich said in a statement, adding that partnering with D-Mark represents a "significant milestone" for the company.

Livermore, California-based S2 has previously forged a collaboration with Dolomite Bio on automated single-cell library prep from tissues; partnered with Japan's RIKEN Center for Integrated Medical Sciences on single-cell genomics applications; and inked distribution agreements in the Asia-Pacific region with Scrum, PharmiGene, LnCBio, Thunderbio Science, and TrendBio.